Rockwell Medical

RMTI

Market cap $37M

WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--Joe Dawson is a seasoned executive who has extensive operational experience and a strong network in the renal care space.

Rockwell Medical, Inc. ( RMTI ) Q3 2025 Earnings Call November 12, 2025 8:00 AM EST Company Participants Heather Hunter - Senior VP & COO Mark Strobeck - President, CEO & Director Jesse Neri - Senior VP & CFO Conference Call Participants Raghuram Selvaraju - H.C. Wainwright & Co, LLC, Research Division Nicholas Sherwood - Maxim Group LLC, Research Division Anthony Vendetti - Maxim Group LLC, Research Division Presentation Operator Good morning, and welcome to Rockwell Medical's Third Quarter 2025 Results Conference Call and Webcast.

Rockwell Medical (RMTI) came out with a quarterly loss of $0.05 per share versus the Zacks Consensus Estimate of a loss of $0.04. This compares to earnings of $0.05 per share a year ago.

WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--Rockwell Medical achieved profitability on an Adjusted EBITDA basis for the third quarter 2025.

WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--Mr. Brown has built a distinguished career leading complex manufacturing and supply chain organizations.

WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--Come visit Rockwell Medical in Booth #316 at ASN Kidney Week 2025 in Houston, TX.

WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--Our team's hard work and dedication are what make Rockwell Medical a leader in our industry and an exceptional place to build a career.

WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--Rockwell Medical will release its results for the third quarter ended September 30, 2025 on Wednesday, November 12, 2025.

WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--Heather Hunter was promoted to Chief Operating Officer, having previously served as Chief Corporate Affairs Officer since August 2022.

Rockwell Medical (RMTI) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).